Less Than Half of Cancer Patients Informed of Fertility Preservation Options
Kim Kincaid had just met with her doctor to start planning a family when...
Pfizer Extends Subsequent Offering Period of Tender Offer to Acquire Icagen, Inc.
Pfizer Inc. and Icagen, Inc. announced today that Pfizer’s wholly-owned subsidiary, Eclipse Acquisition Corp.,...
Mayo Clinic Teams with Glowing Cats Against AIDS, Other Diseases
Mayo Clinic researchers have developed a genome-based immunization strategy to fight feline AIDS and...
Exelixis Announces Webcasts of Upcoming Investor Conference Presentations Exelixis Inc.
Exelixis, Inc. announced today that Michael Morrissey, PhD, the company’s president and chief executive...
Sucampo and Numab Sign Drug Discovery Collaboration Sucampo Pharmaceuticals Inc. and Numab AG
Sucampo Pharmaceuticals, Inc. an international pharmaceutical company, and Numab AG today announced that Sucampo’s...
Trophos completes patient enrolment in pivotal efficacy study of olesoxime in Spinal Muscular Atrophy
Marseille France, September 8, 2011 - Trophos SA, a clinical stage pharmaceutical company developing innovative...
Over 65% of Physicians Have Used Social Media to Support their Professional Practice
Physicians are highly engaged with social media for both personal and professional use, according...
BARDA Partners to Develop New Class of Antibiotic U.S. Department of Health and Human...
The federal government today issued a contract for advanced research and development of a...
Hybrigenics gets approval and funding for a Phase II clinical trial of inecalcitol in...
Hybrigenics, a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research...
Synta to Present at the Rodman & Renshaw Annual Global Investment Conference Synta Pharmaceuticals...
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced that the Company will be presenting at the...
